Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 10, Issue 9, Pages 1926
Publisher
MDPI AG
Online
2021-04-29
DOI
10.3390/jcm10091926
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial
- (2021) Stephan Kadauke et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia
- (2021) Patrick A. Brown et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia
- (2021) Franco Locatelli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group
- (2021) Shinsuke Hirabayashi et al. LEUKEMIA
- Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
- (2021) Vinod A. Pullarkat et al. Cancer Discovery
- Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL)
- (2020) Liora M Schultz et al. BLOOD
- A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia
- (2020) Amir Enshaei et al. BLOOD
- Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study
- (2020) Michael J Burke et al. CLINICAL CANCER RESEARCH
- Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
- (2020) Shuhong Shen et al. JAMA Oncology
- Acute lymphoblastic leukaemia
- (2020) Florent Malard et al. LANCET
- How we prevent infections in patients receiving CD19-targeted chimeric antigen receptor T-cells for B-cell malignancies
- (2020) Joshua A. Hill et al. BLOOD
- Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children’s Oncology Group Study AALL1131
- (2020) Wanda L. Salzer et al. JOURNAL OF CLINICAL ONCOLOGY
- How we approach Philadelphia chromosome‐positive acute lymphoblastic leukemia in children and young adults
- (2020) William B. Slayton et al. PEDIATRIC BLOOD & CANCER
- Concomitant use of a dual ABL/Src kinase inhibitor eliminates the in vitroefficacy of blinatumomab against Ph+ ALL
- (2020) Jessica Leonard et al. BLOOD
- A Phase I study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)
- (2020) Erica Brivio et al. BLOOD
- Genome-wide association study of susceptibility loci for TCF3-PBX1 acute lymphoblastic leukemia in children
- (2020) Shawn H R Lee et al. JNCI-Journal of the National Cancer Institute
- Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
- (2020) Robin Foà et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence-Based Minireview: What is the role for HSCT or immunotherapy in pediatric hypodiploid B-cell acute lymphoblastic leukemia?
- (2020) Aimee C. Talleur et al. Hematology-American Society of Hematology Education Program
- Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study
- (2020) Monique L den Boer et al. Lancet Haematology
- Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational Study
- (2019) Ching-Hon Pui et al. JOURNAL OF CLINICAL ONCOLOGY
- PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
- (2019) Zhaohui Gu et al. NATURE GENETICS
- Mechanisms of resistance to CAR T cell therapy
- (2019) Nirali N. Shah et al. Nature Reviews Clinical Oncology
- Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL
- (2019) Xiaoyuan He et al. LEUKEMIA
- SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain
- (2019) Paul B. Sinclair et al. LEUKEMIA
- Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia
- (2019) David T Teachey et al. LANCET ONCOLOGY
- NUTM1 is a recurrent fusion gene partner in B cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2
- (2019) Femke M Hormann et al. HAEMATOLOGICA
- Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation
- (2019) Brice Mouttet et al. HAEMATOLOGICA
- CD371 cell surface expression: A unique feature of DUX4-rearranged acute lymphoblastic leukemia
- (2019) Dagmar Schinnerl et al. HAEMATOLOGICA
- BCL-2 is a Therapeutic Target For Hypodiploid B-Lineage Acute Lymphoblastic Leukemia
- (2019) Ernesto Diaz-Flores et al. CANCER RESEARCH
- Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR-T cells
- (2019) Kevin A. Hay et al. BLOOD
- Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group
- (2019) Jennifer L. McNeer et al. JOURNAL OF CLINICAL ONCOLOGY
- Natural history and cell-of-origin of TCF3-ZNF384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL
- (2019) Clara Bueno et al. BLOOD
- Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study
- (2019) Rob Pieters et al. JOURNAL OF CLINICAL ONCOLOGY
- The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in ≈0.6% of healthy newborns
- (2019) Daniel Hein et al. BLOOD
- Efficacy of Tyrosine Kinase Inhibitors in Ph-like Acute Lymphoblastic Leukemia harboring ABL-class Rearrangements
- (2019) Ilaria Tanasi et al. BLOOD
- Clinical Experience with Venetoclax in Combination with Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia
- (2019) Guillaume Richard-Carpentier et al. Clinical Lymphoma Myeloma & Leukemia
- Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances
- (2019) Irene Della Starza et al. Frontiers in Oncology
- Safety, Efficacy, and PK of the BCL2 Inhibitor Venetoclax in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Phase 1 Study
- (2019) Seth E Karol et al. BLOOD
- Efficacy and Safety of CAR19/22 T-cell "Cocktail" Therapy in Patients with Refractory/ Relapsed B-Cell Malignancies
- (2019) Na Wang et al. BLOOD
- Sequential CD19-22 CAR T therapy induces sustained remission in children with r/r B-ALL
- (2019) Jing Pan et al. BLOOD
- Treatment of testicular relapse of B-cell acute lymphoblastic leukemia with CD19-specific chimeric antigen receptor T cells
- (2019) Xiaojuan Chen et al. Clinical Lymphoma Myeloma & Leukemia
- Immunotherapy in pediatric acute lymphoblastic leukemia
- (2019) Hiroto Inaba et al. CANCER AND METASTASIS REVIEWS
- The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability
- (2019) Yun Huang et al. CANCER CELL
- Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16
- (2019) Sima Jeha et al. JOURNAL OF CLINICAL ONCOLOGY
- Five percent of healthy newborns have anETV6-RUNX1fusion as revealed by DNA-based GIPFEL screening
- (2018) Daniel Schäfer et al. BLOOD
- Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia
- (2018) Nicola Gökbuget et al. BLOOD
- Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group
- (2018) Kathryn G. Roberts et al. BLOOD
- Management of important adverse events associated with inotuzumab ozogamicin: expert panel review
- (2018) Partow Kebriaei et al. BONE MARROW TRANSPLANTATION
- IKZF1plus Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
- (2018) Martin Stanulla et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children
- (2018) Maoxiang Qian et al. JOURNAL OF CLINICAL ONCOLOGY
- Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0622
- (2018) William B. Slayton et al. JOURNAL OF CLINICAL ONCOLOGY
- Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia
- (2018) David O’Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000)
- (2018) Martin Schrappe et al. JOURNAL OF CLINICAL ONCOLOGY
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia
- (2018) Matthew J. Oberley et al. PEDIATRIC BLOOD & CANCER
- Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia
- (2018) Andrew E. Place et al. PEDIATRIC BLOOD & CANCER
- Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini–Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia
- (2018) Elias Jabbour et al. JAMA Oncology
- Clinical and molecular characteristics of MEF2D fusion-positive precursor B-cell acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion
- (2018) Kentaro Ohki et al. HAEMATOLOGICA
- The genetic basis and cell of origin of mixed phenotype acute leukaemia
- (2018) Thomas B. Alexander et al. NATURE
- Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
- (2018) Elena J. Orlando et al. NATURE MEDICINE
- Tumor Antigen Escape from CAR T-cell Therapy
- (2018) Robbie G. Majzner et al. Cancer Discovery
- How I treat infant leukemia
- (2018) Patrick Brown et al. BLOOD
- Somatic and germline genomics in paediatric acute lymphoblastic leukaemia
- (2018) Ching-Hon Pui et al. Nature Reviews Clinical Oncology
- Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases
- (2018) Jian-Feng Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
- (2017) Yu Liu et al. NATURE GENETICS
- CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
- (2017) Terry J Fry et al. NATURE MEDICINE
- Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
- (2017) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia
- (2016) S. L. Khaw et al. BLOOD
- Near-haploid and low-hypodiploid acute lymphoblastic leukemia: two distinct subtypes with consistently poor prognosis
- (2016) Setareh Safavi et al. BLOOD
- Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype
- (2016) N. Jain et al. BLOOD
- Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking
- (2016) Friederike Braig et al. BLOOD
- ZNF384 -related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype
- (2016) Shinsuke Hirabayashi et al. HAEMATOLOGICA
- MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents
- (2016) Kyogo Suzuki et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy
- (2016) C-H Pui et al. LEUKEMIA
- Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children
- (2016) M Kato et al. LEUKEMIA
- Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults
- (2016) Takahiko Yasuda et al. NATURE GENETICS
- Deregulation of DUX4 and ERG in acute lymphoblastic leukemia
- (2016) Jinghui Zhang et al. NATURE GENETICS
- Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
- (2016) Hagop M. Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity
- (2016) Elad Jacoby et al. Nature Communications
- Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia
- (2016) Henrik Lilljebjörn et al. Nature Communications
- ZNF384 -related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype
- (2016) Shinsuke Hirabayashi et al. HAEMATOLOGICA
- T-cell acute lymphoblastic leukemia
- (2016) E. A. Raetz et al. Hematology-American Society of Hematology Education Program
- Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis
- (2016) Valentino Conter et al. Lancet Haematology
- Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia
- (2016) Yuan-Fang Liu et al. EBioMedicine
- IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients
- (2015) M. A. Pulsipher et al. BLOOD
- Blood Spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease
- (2015) C. J. Harrison BLOOD
- CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
- (2015) S. L. Maude et al. BLOOD
- Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies
- (2015) J. J. M. van Dongen et al. BLOOD
- Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein
- (2015) H. Qin et al. BLOOD
- Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study
- (2015) Elias Jabbour et al. LANCET ONCOLOGY
- Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options
- (2015) Ute Fischer et al. NATURE GENETICS
- Acute Lymphoblastic Leukemia in Children
- (2015) Stephen P. Hunger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
- (2015) E. Sotillo et al. Cancer Discovery
- Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
- (2015) Kathryn G. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia
- (2014) S. Peirs et al. BLOOD
- Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003
- (2014) Katharine Patrick et al. BRITISH JOURNAL OF HAEMATOLOGY
- Detection of Minimal Residual Disease in B Lymphoblastic Leukemia by High-Throughput Sequencing of IGH
- (2014) D. Wu et al. CLINICAL CANCER RESEARCH
- Outcomes of Children With BCR-ABL1–Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease
- (2014) Kathryn G. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- Clonal origins of ETV6-RUNX1+ acute lymphoblastic leukemia: studies in monozygotic twins
- (2014) D Alpar et al. LEUKEMIA
- Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031
- (2014) K R Schultz et al. LEUKEMIA
- Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia
- (2014) Yilong Li et al. NATURE
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maturation Stage of T-cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199
- (2014) T. N. Chonghaile et al. Cancer Discovery
- Recent progress toward epigenetic therapies: the example of mixed lineage leukemia
- (2013) T. Neff et al. BLOOD
- Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia
- (2013) Joshua Yew-Suang Lim et al. CANCER
- Risk-Directed Treatment Intensification Significantly Reduces the Risk of Relapse Among Children and Adolescents With Acute Lymphoblastic Leukemia and Intrachromosomal Amplification of Chromosome 21: A Comparison of the MRC ALL97/99 and UKALL2003 Trials
- (2013) Anthony V. Moorman et al. JOURNAL OF CLINICAL ONCOLOGY
- Intrachromosomal Amplification of Chromosome 21 Is Associated With Inferior Outcomes in Children With Acute Lymphoblastic Leukemia Treated in Contemporary Standard-Risk Children's Oncology Group Studies: A Report From the Children's Oncology Group
- (2013) Nyla A. Heerema et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute lymphoblastic leukaemia
- (2013) Hiroto Inaba et al. LANCET
- An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome
- (2013) C J Harrison et al. LEUKEMIA
- Differential expression of miR-17∼92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia
- (2013) M Scherr et al. LEUKEMIA
- The genomic landscape of hypodiploid acute lymphoblastic leukemia
- (2013) Linda Holmfeldt et al. NATURE GENETICS
- Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
- (2012) Y. H. Messinger et al. BLOOD
- Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
- (2012) M. Faham et al. BLOOD
- Cancer epigenomics: beyond genomics
- (2012) Juan Sandoval et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
- (2012) Jinghui Zhang et al. NATURE
- Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia
- (2012) Martin Schrappe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study
- (2011) M. Schrappe et al. BLOOD
- ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy
- (2011) D Bhojwani et al. LEUKEMIA
- Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005
- (2010) Maurizio Aricò et al. JOURNAL OF CLINICAL ONCOLOGY
- PHF6 mutations in T-cell acute lymphoblastic leukemia
- (2010) Pieter Van Vlierberghe et al. NATURE GENETICS
- Potentiating effects of RAD001 (Everolimus) on vincristine therapy in childhood acute lymphoblastic leukemia
- (2009) R. Crazzolara et al. BLOOD
- High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
- (2009) A. Gutierrez et al. BLOOD
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
- (2009) Elaine Coustan-Smith et al. LANCET ONCOLOGY
- A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
- (2009) Monique L Den Boer et al. LANCET ONCOLOGY
- Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1
- (2009) S Jeha et al. LEUKEMIA
- Deletion ofIKZF1and Prognosis in Acute Lymphoblastic Leukemia
- (2009) Charles G. Mullighan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
- (2009) Ching-Hon Pui et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now